ArticleJCO precision oncology2023
Nodular Regenerative Hyperplasia of the Liver Associated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor in a Patient With Metastatic Renal Cell Carcinoma.
Shannon Rudolph, Mingjia Li, Jinesh Gheeya, Danielle Zimmerman, Ming Yin, Steven K Clinton, Anil V Parwani, Yuanquan Yang
Open access · greenAbstract read
In one paragraphArticle in JCO precision oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 1 institution in 1 country.
Shannon RudolphThe College of Medicine, The Ohio State University, Columbus, OH.
Mingjia LiDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-3910-4179 Jinesh GheeyaDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-5246-6262 Danielle ZimmermanDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0003-2189-2864 Ming YinDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Steven K ClintonDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Anil V ParwaniDepartment of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Yuanquan YangDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-5209-9247 The Ohio State University · US
Funding
Translational Training Grant in Experimental TherapeuticsK12CA133250 · NCI · OHIO STATE UNIVERSITY · PI WILLIAM E. CARSON, Rosa Lapalombella · 2008 to 2026
$15.0MTraining Hematology and Oncology Fellows in Clinical ResearchT32CA247815 · NCI · OHIO STATE UNIVERSITY · PI VERSCHRAEGEN, CLAIRE F., WESOLOWSKI, ROBERT · 2020 to 2024
$862kNCI NIH HHS K12 CA133250NCI NIH HHS T32 CA247815
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Renal CellKidney NeoplasmsAngiogenesis InhibitorsHumansHyperplasiaLiverProtein-Tyrosine KinasesTyrosine Kinase InhibitorsVascular Endothelial Growth Factor AAngiogenesis InhibitorsProtein-Tyrosine KinasesTyrosine Kinase InhibitorsVascular Endothelial Growth Factor A
Identifiers
PMID37053537
PMCPMC10530936
OpenAlexW4365458198
What OpenQuestion holds
Textmetadata
Read underepoch 390